SCHEMBL19644477

SCHEMBL19644477

Cn1cc(-c2cc3c(cc2C(F)F)N(c2ccc4c(c2)CN(C(=O)O)CCO4)CCC3)cn1

nearest known ligand 0.88

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 20/20 0.88
BRD4 O60885 4/20 0.85
EP300 Q09472 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19643773 0.94 CREBBP (1.00) CREBBPBRD4EP300
SCHEMBL19643502 0.92 CREBBP (1.00) CREBBPBRD4EP300
SCHEMBL19644157 0.92 CREBBP (1.00) CREBBPBRD4EP300
SCHEMBL19644377 0.90 CREBBP (0.82) CREBBPBRD4EP300
SCHEMBL19657917 0.88 CREBBP (0.78) CREBBPBRD4EP300
SCHEMBL19644414 0.83 CREBBP (0.70) CREBBPBRD4EP300
SCHEMBL19643617 0.81 CREBBP (1.00) CREBBPBRD4EP300
SCHEMBL24258497 0.80 CREBBP (0.67) CREBBPBRD4EP300
SCHEMBL19657394 0.80 CREBBP (0.80) CREBBPBRD4EP300
SCHEMBL19644549 0.80 CREBBP (1.00) CREBBPBRD4EP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464270-A2 HETEROCYCLIC INHIBITORS OF CBP/EP300 AND THEIR USE IN THE TREATMENT OF CANCER Genentech, Inc. (US) 2019-04-10 EP disclosed
WO-2017205536-A2 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2017-11-30 WO disclosed